Ask My DNA Blog

18 min read
3,868 words

Magnesium Genetics: TRPM6, TRPM7, and Cellular Energy

Millions of people experience persistent fatigue, muscle cramps, and irregular heartbeats despite consuming adequate magnesium through diet and supplements. According to research published in Biochemical and Biophysical Research Communications (2015), genetic variants in the TRPM6 and TRPM7 genes explain why standard supplementation fails for certain individuals. These genes control how your body absorbs, transports, and utilizes magnesium—and if you carry specific variants, you may need 2-3 times more magnesium than standard recommendations suggest.

This guide explores how genetic variations in magnesium channel proteins affect energy production, muscle function, and metabolic health. Understanding your TRPM6 and TRPM7 genetic profile reveals personalized magnesium needs that standard testing cannot detect, enabling targeted optimization strategies that actually work.

Understanding Magnesium Genetics: TRPM6, TRPM7 Mechanisms

TRPM6 and TRPM7 are magnesium channel proteins that function as gatekeepers of magnesium metabolism. TRPM6 primarily manages intestinal absorption and kidney reabsorption, determining how much dietary magnesium enters your bloodstream. TRPM7 regulates intracellular magnesium availability in virtually all cells, directly affecting ATP synthesis and cellular energy production. Genetic variants in these genes can reduce magnesium absorption efficiency by 30-40%, creating deficiency symptoms despite adequate dietary intake.

What Are TRPM6 and TRPM7?

TRPM6 and TRPM7 are ion channel proteins belonging to the transient receptor potential melastatin family. These channels allow magnesium ions (Mg2+) to pass through cell membranes—a process requiring specialized molecular recognition. TRPM6 contains binding sites that recognize and transport magnesium with remarkable selectivity across intestinal and kidney cells. Without functioning TRPM6 channels, your intestines struggle to absorb dietary magnesium regardless of intake amount, similar to having a broken gate in a fence.

TRPM7 takes a different role. While TRPM6 controls the gateway at absorption sites, TRPM7 acts as the intracellular magnesium manager, present in every tissue from brain to muscle mitochondria. Research published in eLife (2017) demonstrated that TRPM7 contains a unique kinase domain—essentially a cellular control switch—allowing cells to regulate magnesium availability based on metabolic demands. This is why TRPM7 variants produce different symptoms than TRPM6 variants: the problem lies not in absorption, but in getting magnesium into cells where it's needed.

TRPM6: The Absorption Gatekeeper

TRPM6 functions primarily in two locations: the intestinal epithelium and kidney tubules. In the intestine, TRPM6 channels actively transport magnesium from your digestive tract into your bloodstream. The kidney then uses additional TRPM6 channels to reabsorb filtered magnesium, conserving roughly 99% of blood magnesium that your body has worked to absorb.

Genetic variants in TRPM6 disrupt this efficiency at one or both steps. The most well-characterized variants are rs3750425 (affecting intestinal absorption) and rs2274924 (influencing kidney reabsorption). Carriers of risk variants experience 30-40% reduced absorption efficiency, meaning someone consuming 400mg of magnesium daily might absorb only 240-280mg—below optimal amounts. According to a 2009 study in BMC Medical Genetics, women carrying TRPM6 risk variants showed significantly lower serum magnesium despite similar dietary intake to non-carriers.

Compounding this challenge, TRPM6 variants disable the adaptive response that normally increases absorption when magnesium stores run low. People with TRPM6 variants lack this compensatory mechanism, making them vulnerable to deficiency despite increased intake attempts.

TRPM7: The Cellular Regulator

TRPM7 operates in virtually all cell types, making it universally important for magnesium function. Unlike TRPM6's localized absorption role, TRPM7 regulates intracellular magnesium levels that directly control ATP synthesis—the energy currency of every cell. Mitochondria rely on magnesium as an essential cofactor for ATP synthase, the molecular machine generating usable energy.

The TRPM7 variant rs8042919 affects the channel's kinase domain—a cellular magnesium sensor. When magnesium runs low inside cells, TRPM7 normally shifts into a mode increasing magnesium permeability. Variants impairing this sensing mechanism leave cells unable to properly detect and respond to magnesium deficiency, creating scenarios where cells remain functionally magnesium-depleted even with apparently adequate tissue levels.

TRPM7 also plays roles beyond ATP production. Magnesium serves as a cofactor for DNA polymerases, for proteins regulating muscle contraction, and for neurotransmitter synthesis affecting mood and stress response. TRPM7 variants therefore create cascading effects across multiple physiological systems.

TRPM6/TRPM7 Interaction

Research from the Max Planck Institute (2017) revealed that TRPM6 and TRPM7 can form heteromeric channels—combined protein complexes where the two channels work together as a single unit. This interaction explains paradoxical cases where people with normal absorption genetics still develop magnesium deficiency symptoms: if their TRPM7 variants severely impair cellular uptake, absorbed magnesium never reaches cells needing it—supply-side abundance coupled with demand-side deficiency.

<!-- IMAGE: TRPM6 vs TRPM7 Functions comparison | Alt: Diagram comparing TRPM6 magnesium absorption pathway in intestine and kidney versus TRPM7 intracellular magnesium utilization in cellular energy production -->

How Magnesium Genetics Impact Your Health

Magnesium affects more physiological systems than perhaps any other mineral. When TRPM6 or TRPM7 variants reduce magnesium availability, effects ripple across energy production, muscle function, cardiovascular health, and metabolic regulation.

Energy Production & Cellular Metabolism

Magnesium serves as a cofactor for over 300 enzymatic reactions, with ATP-related reactions being the most critical. ATP synthase—the molecular turbine generating ATP—requires magnesium. The enzyme breaking down ATP to release energy requires magnesium. Every step of ATP metabolism depends on adequate cellular magnesium, making deficiency functionally similar to having broken cellular generators.

According to research in Magnesium Research (2014), individuals with TRPM7 variants experience 15-25% reduction in ATP synthesis capacity—equivalent to cellular power plants operating at 75-85% efficiency. For sedentary individuals this means chronic fatigue and poor recovery. For athletes, this translates to earlier exhaustion during training and slower recovery between sessions.

Muscle Function and Athletic Performance

Magnesium controls muscle contraction through its regulation of calcium channels and ATP availability for muscle fiber operation. When magnesium runs low, calcium channels become hypersensitive, causing involuntary muscle contractions—cramping. Simultaneously, reduced ATP availability makes muscle relaxation difficult, creating partial contraction states athletes recognize as tightness.

Individuals with TRPM6 variants frequently experience muscle cramps despite supplementation, because standard forms don't absorb adequately enough. Those with TRPM7 variants experience different patterns—normal blood magnesium but cellular deficiency creates cramping during intense exercise, because cells can't mobilize intracellular magnesium rapidly enough.

Athletic performance research reveals dramatic improvements when genetic-informed magnesium optimization corrects these deficiencies. Studies show that magnesium-replete athletes demonstrate 10-15% better recovery time and improved power output.

Cardiovascular & Metabolic Health

Magnesium regulates blood vessel relaxation, making it essential for blood pressure control. According to a 2017 study in the Journal of the American Heart Association, TRPM6 and TRPM7 variants correlate with elevated blood pressure even when lifestyle factors appear optimal.

More concerning, TRPM6 and TRPM7 variants increase Type 2 Diabetes risk by 1.5-2x according to genome-wide association studies published in BMC Medical Genetics. The mechanism involves magnesium-dependent enzymes controlling glucose metabolism, impaired insulin secretion from pancreatic cells with low intracellular magnesium, and insulin resistance. For women, TRPM6/TRPM7 variants increase gestational diabetes risk, creating potential pregnancy complications mitigated through genetic-guided supplementation.

Beyond blood sugar, magnesium regulates dozens of cardiovascular functions: arrhythmia susceptibility, inflammation markers, endothelial function, and blood viscosity. People with genetic magnesium deficiency often show multiple cardiovascular risk markers that improve dramatically once adequate magnesium reaches cellular targets—blood pressure drops, triglycerides normalize, and arrhythmia frequency decreases.

Neurological and Stress Response

Your brain contains roughly 24% of your body's magnesium, concentrated particularly in neurons and synaptic membranes. Magnesium modulates excitatory neurotransmission, essentially setting your nervous system's sensitivity to stimuli. Low magnesium increases neuronal excitability—the sensation of being "wired" or reactive to minor stressors, and increases seizure susceptibility.

Migraines correlate strongly with magnesium status. Research indicates that magnesium depletion lowers seizure thresholds in brain regions controlling migraine generation, making migraines more likely and severe. People with TRPM6 or TRPM7 variants who suffer migraines often find frequency and intensity drop 30-50% once genetic-informed supplementation establishes adequate magnesium status.

Stress response provides another critical connection. Magnesium is required for hypothalamic-pituitary-adrenal axis function and for synthesis of serotonin and mood-regulating neurotransmitters. During stress, your body depletes magnesium 2-3x faster than normal, creating a vicious cycle: stress depletes magnesium, low magnesium impairs stress response, making you vulnerable to further stress.

Genetic Testing for Magnesium Absorption & Utilization

Understanding your TRPM6 and TRPM7 genetics shifts magnesium optimization from guesswork to precision. Genetic testing identifies which specific SNPs you carry and therefore exactly how much magnesium intervention you require.

Which Genetic Variants Matter?

The most well-researched TRPM6 variants are rs3750425 (affecting intestinal magnesium absorption) and rs2274924 (influencing kidney magnesium reabsorption). Having either variant increases magnesium requirements; having both creates substantially higher needs.

For TRPM7, the rs8042919 variant impairs the kinase domain's ability to sense and respond to intracellular magnesium deficiency, creating cellular deficit even when blood magnesium appears adequate. Carriers often experience a peculiar scenario: standard magnesium testing shows normal levels, yet they experience severe deficiency symptoms.

Beyond these primary SNPs, dozens of additional variants in TRPM6 and TRPM7 show effects in research studies, though most prove less clinically significant. A comprehensive nutrigenomic panel examines multiple genes in the magnesium metabolism pathway, providing complete picture of your individual absorption and utilization capacity.

When Should You Get Tested?

Genetic testing becomes particularly valuable when you experience unexplained symptoms despite seemingly appropriate diet and supplementation. The classic presentation includes chronic muscle cramping, persistent fatigue despite adequate sleep, heart palpitations, migraines, or exercise intolerance where you cannot maintain performance despite good conditioning.

Another important trigger is discovering that standard serum magnesium testing shows normal levels while you experience magnesium deficiency symptoms. This paradox strongly suggests TRPM7 variants or other cellular uptake problems, because it indicates magnesium in your blood fails to translate into cellular adequacy. Since serum magnesium measures less than 1% of your body's total magnesium, blood tests miss cellular deficiency entirely.

Testing Methods & Interpretation

Most nutrigenomic testing panels use next-generation sequencing (NGS) to analyze TRPM6, TRPM7, and related genes. The testing requires only a DNA sample—typically saliva—and takes 3-4 weeks. Reputable providers should maintain CLIA certification, ensuring laboratory quality standards and result accuracy.

Interpretation requires understanding that genetic effects work probabilistically. Carrying one copy of a TRPM6 risk variant increases magnesium deficiency susceptibility roughly 1.3-1.6x above baseline. Carrying two copies creates much stronger effects, potentially doubling magnesium requirements. Combining multiple variant-carrying genes creates cumulative effects where needs might triple compared to non-carriers.

Genetic testing results gain context when paired with RBC magnesium testing, which measures magnesium inside your red blood cells—a proxy for intracellular magnesium status. A person with normal serum magnesium but low RBC magnesium confirms a cellular uptake problem (TRPM7-type), while low both values suggests absorption problems (TRPM6-type). This combination—genetic data plus RBC testing—provides complete diagnostic clarity.

Hypomagnesemia with Secondary Hypocalcemia (HSH)

Severe TRPM6 mutations cause Hypomagnesemia with Secondary Hypocalcemia, a clinical condition distinct from common genetic variants. HSH represents the extreme end of TRPM6 dysfunction: complete loss of intestinal magnesium absorption combined with inability to reabsorb filtered magnesium in the kidney. Patients develop severe blood magnesium depletion and secondary low blood calcium, creating seizure risk and potential cardiac arrhythmias.

HSH diagnosis, while rare, matters because it requires aggressive intervention beyond supplementation: intravenous magnesium infusions and careful electrolyte management. Most TRPM6 genetic variants don't cause HSH but create milder versions of the same mechanism—reduced but not absent absorption.

Personalized Strategies Based on Your Magnesium Genetics

Once you understand your genetic profile, optimization becomes straightforward. Different genetic profiles require different supplement forms, dosing schedules, and dietary approaches.

Dietary Optimization by Genetic Profile

TRPM6 variant carriers benefit enormously from dietary magnesium, as food-based absorption often exceeds supplement-based absorption. However, combination matters: magnesium absorbs best when consumed with dietary fat. Pumpkin seeds (180mg magnesium per quarter cup) combined with avocado, dark chocolate with almonds, or spinach salad with olive oil—these combinations leverage both high magnesium content and absorption-enhancing fats.

Target 450-550mg daily from food sources for TRPM6 variant carriers, focusing on consistent intake rather than intermittent large amounts. Distributed intake throughout the day maximizes total absorption, as your intestines cannot absorb 400mg from a single meal.

Supplement Selection Guide

Magnesium supplements exist in numerous forms, each with different bioavailability. The oxide form provides cheap magnesium but absorbs poorly (40%) and causes laxative effects—a poor choice for anyone but particularly problematic for TRPM6 carriers. Carbonate and citrate forms absorb faster (70-75%) but citrate creates laxative effects.

For TRPM6 variants, select highly bioavailable chelated forms: glycinate (90%+ bioavailability), threonate (85%+, with added brain-health properties), or bisglycinate (88%+, exceptionally well-tolerated). Take these in smaller doses—100-150mg 3-4 times daily—to maximize absorption by not overwhelming your impaired capacity. Divided dosing also prevents laxative effects occurring when magnesium overwhelms intestinal capacity.

For TRPM7 variants, prioritize forms supporting energy production. Magnesium malate (75% bioavailability) specifically supports mitochondrial function through its role in the Krebs cycle. Magnesium taurate (80% bioavailability) combines magnesium with taurine, an amino acid supporting cardiovascular function and cellular energy. Magnesium orotate (85% bioavailability) provides magnesium plus orotic acid supporting ATP synthesis.

FormBioavailabilityBest ForTypical DoseKey Notes
Glycinate90%+TRPM6 variants150mg 3-4x dailyNo laxative effect, gentle absorption
Threonate85%+TRPM6 + brain health100-150mg 2-3xCrosses blood-brain barrier
Bisglycinate88%+TRPM6 variants150mg 3-4x dailyHighly absorbable chelate
Malate75%+TRPM7 variants200mg 2-3xSupports Krebs cycle, energy
Taurate80%+TRPM7 + cardiovascular150mg 2-3xCardiovascular support
Citrate70%General use200mg 2xMild laxative effect
Oxide40%AvoidNot recommendedPoor absorption, strong laxative

Lifestyle & Environmental Factors

Stress depletes magnesium 2-3x faster than normal, particularly in people with genetic variants operating from a depleted baseline. During high-stress periods, your magnesium needs can rise 50-100% above baseline. Understanding this relationship means consciously prioritizing magnesium supplementation during high-stress periods.

Exercise similarly depletes magnesium: intense training sessions, endurance activities, and even moderate regular exercise increase magnesium needs. Alcohol accelerates magnesium loss through multiple mechanisms: direct urinary losses, impaired absorption, and stress-pathway activation. People with genetic magnesium deficiency should carefully limit alcohol or accept needing higher supplementation.

Sleep quality improves dramatically with adequate cellular magnesium, particularly in people with TRPM7 variants where evening magnesium dosing allows intracellular magnesium accumulation overnight. Many people report significant sleep improvement within 1-2 weeks of starting appropriately-dosed magnesium.

Monitoring & Long-term Optimization

RBC magnesium testing every 3-4 months provides objective feedback on whether your supplementation strategy achieves target magnesium status. A normal RBC magnesium level (4.0-6.4 mg/dL) indicates adequate cellular magnesium; levels below 3.5 mg/dL suggest persistent deficiency despite supplementation.

Symptom tracking over weeks and months provides additional valuable data. Most people notice improvement in energy within 4-6 weeks of beginning appropriate supplementation, in athletic performance within 8-12 weeks, and in muscle cramping within 2-4 weeks.

Ask My DNA Integration

Understanding which magnesium form matches your TRPM6 absorption patterns or how your TRPM7 variants affect cellular energy requires personalized genetic analysis. Ask My DNA lets you explore your magnesium genetics in detail, receiving personalized insights on supplementation timing, dosage optimization, and dietary strategies based on your specific genetic profile. Rather than guessing which supplement might work, genetic testing reveals exactly what your body needs.

Advanced Considerations

TRPM6/TRPM7 and Type 2 Diabetes

TRPM6 and TRPM7 variants increase Type 2 Diabetes risk by 1.5-2x according to genome-wide association studies. The mechanisms involve magnesium-dependent enzymes controlling glucose metabolism, magnesium-dependent insulin secretion from pancreatic cells, and insulin sensitivity in target tissues. Adequate magnesium status improves insulin sensitivity by 10-15%, potentially preventing diabetes progression in at-risk individuals.

For women, gestational diabetes risk increases with magnesium deficiency, making pre-pregnancy magnesium optimization particularly relevant for pregnant women or those planning conception.

Genetic Magnesium Needs vs Standard RDA

The standard recommended dietary allowance for magnesium is 310mg daily for adult women and 400mg daily for adult men. These recommendations represent population averages derived from studies in people without known genetic variants. For TRPM6 or TRPM7 variant carriers, these recommendations prove inadequate—variant carriers may require 600-900mg daily to achieve the same intracellular magnesium status as non-carriers consuming 400mg.

FAQ

Q: What are TRPM6 and TRPM7 genes and why do they matter for magnesium?

TRPM6 and TRPM7 encode magnesium channel proteins controlling absorption, transport, and cellular utilization of magnesium. TRPM6 manages intestinal absorption and kidney reabsorption—determining how much dietary magnesium enters your bloodstream. TRPM7 regulates intracellular magnesium in virtually all cell types, affecting ATP synthesis and energy production. Genetic variants in these genes reduce magnesium availability by 30-40%, causing deficiency symptoms despite adequate intake. These genes matter because they determine your individual magnesium requirements, which may be 2-3 times higher than standard recommendations.

Q: Can genetic testing explain why I have low magnesium despite supplementation?

Absolutely. TRPM6 variants reduce intestinal absorption efficiency, meaning standard supplements may not adequately raise tissue levels regardless of dose. TRPM7 variants affect cellular uptake, creating situations where blood magnesium appears normal while cells remain functionally deficient. Genetic testing identifies which mechanism affects you, guiding selection of highly bioavailable supplement forms and optimal dosing schedules that actually correct your specific deficiency.

Q: Which magnesium supplement form works best for TRPM6 or TRPM7 variants?

TRPM6 variants respond best to highly bioavailable chelated forms like magnesium glycinate, threonate, or bisglycinate, taken in smaller divided doses (100-150mg 3-4 times daily) to maximize intestinal absorption. TRPM7 variants benefit from forms supporting mitochondrial function like magnesium malate, taurate, or orotate at 150-200mg twice daily. Many people with both variants benefit from combination products.

Q: How do magnesium genetics affect energy levels and athletic performance?

Magnesium serves as a critical cofactor for ATP synthesis. TRPM7 variants reduce cellular magnesium availability, decreasing ATP production by 15-25% and impairing exercise performance and recovery. TRPM6 variants limit total body magnesium stores, causing earlier fatigue and cramping during physical activity. Genetic-guided magnesium optimization typically improves energy within 4-6 weeks and athletic performance within 8-12 weeks.

Q: What is Hypomagnesemia with Secondary Hypocalcemia (HSH)?

Hypomagnesemia with Secondary Hypocalcemia is a rare genetic condition caused by severe TRPM6 mutations creating complete inability to absorb dietary magnesium. Patients develop profound blood magnesium depletion and secondary low blood calcium, potentially creating seizure risk and cardiac arrhythmias. While HSH itself remains rare, most TRPM6 genetic variants create milder versions—reduced but not absent absorption.

Q: How much magnesium should I take based on my genetic variants?

TRPM6 carriers typically require 450-550mg daily from food sources plus 300-400mg supplemental magnesium in divided doses. TRPM7 carriers benefit from 300-400mg supplemental magnesium in energy-supporting forms. People carrying variants affecting both genes may need 600-900mg total daily. RBC magnesium testing every 3-4 months helps determine if your dosing achieves target status.

Q: What are the specific SNPs I should test for TRPM6 and TRPM7?

The most relevant TRPM6 SNPs are rs3750425 (affecting intestinal absorption) and rs2274924 (affecting kidney reabsorption). The primary TRPM7 SNP is rs8042919 (affecting cellular magnesium sensing and uptake). A comprehensive nutrigenomic panel examines these core variants plus additional magnesium metabolism genes.

Q: How do TRPM6 and TRPM7 affect blood sugar and diabetes risk?

TRPM6 and TRPM7 variants increase Type 2 Diabetes risk by 1.5-2x according to genome-wide association studies. The mechanisms involve magnesium-dependent enzymes controlling glucose metabolism and magnesium-dependent insulin secretion. Adequate magnesium status improves insulin sensitivity by 10-15%, potentially preventing diabetes progression. For women, TRPM6/TRPM7 variants increase gestational diabetes risk.

Q: Can magnesium supplementation prevent genetic magnesium deficiency?

Yes, if you use the right forms and dosages based on your genetic profile. Supplementation cannot reverse genetic variants, but it can correct the magnesium deficiency that variants create. Effectiveness depends on selecting forms your absorption capacity can handle and dosing appropriately based on your specific variants.

Q: Where can I get genetic testing for TRPM6 and TRPM7 variants?

Nutrigenomic testing companies including 23andMe, AncestryDNA, and specialty labs like DNAfit offer TRPM6/TRPM7 testing through genetic panels. Tests cost $150-400 depending on comprehensiveness. When selecting a testing company, verify CLIA certification and that reports include specific SNP information rather than vague categorical results.

Q: What is the difference between serum magnesium and RBC magnesium testing?

Serum magnesium measures magnesium in your blood, representing less than 1% of your body's total magnesium. RBC magnesium measures magnesium inside red blood cells, providing a proxy for intracellular magnesium status. Someone can have perfectly normal serum magnesium yet severely depleted RBC magnesium, indicating cellular deficiency despite adequate blood levels. For people with suspected genetic magnesium deficiency, RBC testing is essential.

Q: How long does it take to feel better after starting magnesium based on my genetics?

Energy improvements typically emerge within 4-6 weeks of appropriate genetic-guided supplementation. Muscle cramping often improves within 2-4 weeks. Athletic performance improvements may require 8-12 weeks. Sleep quality often improves within 1-2 weeks. Individual variation occurs based on baseline deficiency severity and how quickly supplements correct RBC magnesium status.

<!-- IMAGE: Magnesium Supplement Forms by Genetic Profile | Alt: Table comparing magnesium supplement forms with bioavailability percentages and recommendations for TRPM6 versus TRPM7 genetic variants -->

Conclusion

Your TRPM6 and TRPM7 genetics determine how efficiently your body harnesses one of the most critical minerals for energy production, muscle function, and metabolic health. Variants in these genes explain why some people achieve vibrant health from standard magnesium supplementation while others remain symptomatic despite identical doses—because their individual absorption and cellular utilization capacity differs dramatically from population averages.

Genetic testing removes guesswork from magnesium optimization. Rather than trying endless supplement forms hoping something works, you can identify your specific genetic profile and implement a personalized strategy targeting your particular variant combinations. The difference compounds over years: people who optimize magnesium based on genetics achieve better energy, stronger athletic performance, superior muscle function, lower cardiovascular disease risk, and reduced diabetes susceptibility compared to their non-optimized peers carrying identical genetic variants.

Consult with your healthcare provider about genetic testing, and once you understand your specific variants, you possess the knowledge to transform your cellular energy, muscle function, and long-term health trajectory.

đź“‹ Educational Content Disclaimer

This article provides educational information about genetic variants and is not intended as medical advice. Always consult qualified healthcare providers for personalized medical guidance. Genetic information should be interpreted alongside medical history and professional assessment.

References

  1. 1.
    . Biochemical and Biophysical Research Communications. .
  2. 2.
    . Advances in Nutrition. .
  3. 3.
    . Magnesium Research. .
  4. 4.
    . Journal of the American Heart Association. .
  5. 7.
    . Nature. .
  6. 8.
    . DiNicolantonio JJ, O'Keefe JH. .

All references are from peer-reviewed journals, government health agencies, and authoritative medical databases.

Available Now

Stop reading about genetics. Start understanding yours.

Upload your DNA file and ask any question about your personal genome. Get answers in seconds, not weeks.

How it works

1

Upload your DNA file

Drag your raw file from 23andMe, Ancestry, or other services. Takes less than 2 minutes.

2

Ask any question

"Why does coffee affect me this way?" "What vitamins do I need?" "Am I a carrier?"

3

Get personalized answers

Answers based on YOUR genes, not population statistics. With scientific references.

Works with:

23andMeAncestryMyHeritageFTDNA
🧬

Ready to get started?

Discover what your DNA says about you. Personalized answers based on your unique genome.

Get started now

Encrypted · Never shared · GDPR compliant

We use consent-based analytics

Marketing pixels (Meta, Google, LinkedIn, TikTok, Twitter) only activate after you accept. Declining keeps the site fully functional without tracking. Learn more